isothiocyanic acid 1-cyclopentanecarbonyl ester | 1154366-71-8

• 分子结构分类: 有机化合物 - 有机硫化合物 - 异硫氰酸盐
• 英文名称: isothiocyanic acid 1-cyclopentanecarbonyl ester
• 英文别名: isothiocyanic acid cyclopentaneformyl ester；1-Cyclopentanecarbonyl isothiocyanate；cyclopentanecarbonyl isothiocyanate
• CAS: 1154366-71-8
• 化学式: C₇H₉NOS
• mdl: MFCD13680313
• 分子量: 155.221
• InChiKey: SGCJFQAAAFFOMR-UHFFFAOYSA-N

物化性质

• 沸点：
  228.1±7.0 °C(predicted)
• 密度：
  1.22±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.714
• 拓扑面积：
  61.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-噻吩甲酰肼 、 isothiocyanic acid 1-cyclopentanecarbonyl ester 以 乙腈 为溶剂， 反应 1.5h， 生成 N-(2-(thiophene-2-carbonyl)hydrazine-1-carbonothioyl)cyclopentanecarboxamide
  参考文献：
  名称：

  Design, synthesis and anticonvulsant activity of new Diacylthiosemicarbazides

  摘要：

  DOI：

  10.7124/bc.000a46
• 作为产物：
  描述：

  环戊基甲酰氯 、 ammonium thiocyanate 以 乙腈 为溶剂， 反应 0.5h， 生成 isothiocyanic acid 1-cyclopentanecarbonyl ester
  参考文献：
  名称：

  Design, synthesis and anticonvulsant activity of new Diacylthiosemicarbazides

  摘要：

  DOI：

  10.7124/bc.000a46

文献信息

• Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin
  作者：Cheng-Jie Yang、Bin Li、Zhi-Jun Zhang、Jian-Mei Gao、Mei-Juan Wang、Xiao-Bo Zhao、Zi-Long Song、Ying-Qian Liu、Hu Li、Yuyuan Chen、Kuo-Hsiung Lee、Susan L. Morris-Natschke、Chuanrui Xu

  DOI：10.1016/j.ejmech.2019.111971

  日期：2020.2

  research on diverse C-20 decorated derivatives of camptothecin (CPT), 46 new CPT acylthiourea derivatives were synthesized and evaluated in vitro for their cytotoxicity. All the compounds showed promising in vitro cytotoxicity against six tumor cell lines (Hep3B, MCF7, A549, MDA-MB-231, KB and KB-vin). Out of them, compound c20 possesses remarkable in vitro cytotoxic activity and is more potent than topotecan

  为了促进我们对喜树碱（CPT）的各种C-20装饰的衍生物的研究，合成了46种新的CPT酰基硫脲衍生物，并在体外对其细胞毒性进行了评估。所有化合物对六种肿瘤细胞系（Hep3B，MCF7，A549，MDA-MB-231，KB和KB-vin）均显示出有希望的体外细胞毒性。其中，化合物c20具有显着的体外细胞毒性活性，并且比托泊替康更有效。从机理上讲，c20不仅诱导A549细胞的细胞周期停滞和细胞凋亡，而且以类似于拓扑替康的方式抑制细胞和无细胞系统中的Topo I活性。在异种移植和原发性HCC小鼠模型中，c20均显示出显着的体内抗癌活性，并且比托泊替康更有效。此外，急性毒性试验表明，c20对FVB / N小鼠的小鼠肝，肾和造血系统无明显毒性。综上所述，这些结果表明化合物c20可能是用于进一步临床试验的潜在抗癌候选物。
• Novel <i>N</i> ‐Cycloalkylcarbonyl‐ <i>N</i> ′‐arylthioureas: Synthesis, Design, Antifungal Activity and Gene Toxicity
  作者：Olena V. Kholodniak、Maksym S. Kazunin、Fatuma Meyer、Sergiy I. Kovalenko、Karl G. Steffens

  DOI：10.1002/cbdv.202000212

  日期：2020.7

  A synthesis method of novel N‐cycloalkylcarbonyl‐N′‐arylthioureas was developed. It consists of sequential addition of equimolecular amounts of ammonium isothiocyanate and substituted anilines to cycloalkylcarbonyl chlorides. The identity and purity of products were confirmed by LC/MS spectra, their structure by elemental analysis, IR and 1H‐NMR spectra. Preliminary antimicrobial screening for standard

  开发了一种新型N-环烷基羰基-N'-芳基硫脲的合成方法。它包括将等分子量的异硫氰酸铵和取代的苯胺依次添加到环烷基羰基氯中。产品的特性和纯度通过 LC/MS 光谱确认，其结构通过元素分析、IR 和 1H-NMR 光谱确认。标准微生物的初步抗菌筛选和分子对接允许选择几种结构进行抗真菌和遗传毒性研究。对 9 种化合物对 11 种植物病原真菌和三种疫霉属菌株的抗真菌潜力进行了体外筛选，结果表明，浓度为 50 μg/ml 的两种 N-（芳基氨基甲硫酰）环丙烷甲酰胺表现出与标准抗真菌剂“环丙康唑”相当的活性。
• Quinoline and quinazoline derivatives and drugs containing the same
  申请人：——

  公开号：US20040132727A1

  公开（公告）日：2004-07-08

  There are provided compounds which can be used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy. The compounds are those represented by formula (I) or pharmacologically acceptable salts or solvates thereof: 1 wherein R 1 and R 2 represent hydrogen, alkyl or the like; R 3 , R 4 , R 5 and R 6 represent hydrogen, halogen, alkyl, alkoxy or the like; R 11 and R 12 represent hydrogen, alkyl, alkylcarbonyl or the like; and A represents any one of formulae (i) to (x), provided that compounds wherein R 3 , R 4 , R 5 and R 6 represent hydrogen and A represents group (v) wherein u is 0 (zero) and R 19 represents phenyl optionally substituted by halogen, alkyl, or alkoxy are excluded.

  提供了一些化合物，可用于治疗由PDGF受体自磷酸化介导的疾病，特别是可抑制新内膜形成肥大的化合物。这些化合物由式（I）或其药理学上可接受的盐或溶剂表示：1其中R1和R2表示氢，烷基或类似物；R3、R4、R5和R6表示氢，卤素，烷基，烷氧基或类似物；R11和R12表示氢，烷基，烷基羰基或类似物；而A表示公式（i）到（x）中的任意一个，但其中R3、R4、R5和R6表示氢，A表示组（v）其中u为0（零）且R19表示苯基，可选地被卤素，烷基或烷氧基取代的化合物被排除。
• QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME
  申请人：KIRIN BEER KABUSHIKI KAISHA

  公开号：EP1243582A1

  公开（公告）日：2002-09-25

  There are provided compounds which can be used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy. The compounds are those represented by formula (I) or pharmacologically acceptable salts or solvates thereof: wherein R1 and R2 represent hydrogen, alkyl or the like; R3, R4, R5, and R6 represent hydrogen, halogen, alkyl, alkoxy or the like; R11 and R12 represent hydrogen, alkyl, alkylcarbonyl or the like; and A represents any one of formulae (i) to (x), provided that compounds wherein R3, R4, R5 and R6 represent hydrogen and A represents group (v) wherein u is 0 (zero) and R19 represents phenyl optionally substituted by halogen, alkyl, or alkoxy are excluded.

  提供了可用于治疗由 PDGF 受体自身磷酸化介导的疾病的化合物，特别是可抑制新内膜形成肥厚的化合物。这些化合物是式 (I) 所代表的化合物或其药理学上可接受的盐或溶液： 其中 R1 和 R2 代表氢、烷基或类似物；R3、R4、R5 和 R6 代表氢、卤素、烷基、烷氧基或类似物；R11 和 R12 代表氢、烷基、烷基羰基或类似物；A 代表式(i)至(x)中的任意一种，但不包括 R3、R4、R5 和 R6 代表氢且 A 代表基团(v)（其中 u 为 0（零）且 R19 代表任选被卤素、烷基或烷氧基取代的苯基）的化合物。
• Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors
  作者：Iou-Jiun Kang、Li-Wen Wang、Sheng-Ju Hsu、Chung-Chi Lee、Yen-Chun Lee、Yen-Shian Wu、Tsu-An Hsu、Andrew Yueh、Yu-Sheng Chao、Jyh-Haur Chern

  DOI：10.1016/j.bmcl.2009.06.009

  日期：2009.8

  An efficient synthetic methodology to provide indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives is described. These conformationally restricted heterobicyclic scaffolds were evaluated as a novel class of HCV inhibitors. Introduction of an acyl group at the NH2 of the thiourea moiety has been found to enhance inhibitory activity. The chain length and the position of the alkyl group on the indoline aromatic ring markedly influenced anti-HCV activity. The indoline scaffold was more potent than the corresponding indole and tetrahydroquinoline scaffolds and analogue 31 displayed excellent activity (EC50 = 510 nM) against HCV without significant cytotoxicity (CC50 > 50 mu M). (C) 2009 Elsevier Ltd. All rights reserved.